This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Abgenomics Cooperatief U.a.. Active years: 2009-2018.
Company Filing History:
Years Active: 2009-2018
Title: Pei-Jiun Chen: Innovator in Immunology
Introduction
Pei-Jiun Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 7 patents to his name, Chen's work focuses on advancing treatments for various immune-related conditions.
Latest Patents
Among his latest patents are methods of treating with anti-PSGL-1 antibodies. These patents detail immunoglobulin chains or antibodies that possess light or heavy chain complementarity determining regions, specifically targeting P-Selectin Glycoprotein Ligand-1. Additionally, he has disclosed methods for inducing the death of activated T-cells and modulating T cell-mediated immune responses in subjects. His work also includes methods for treating graft-versus-host disease (GVHD) and transplant rejection using anti-PSGL-1 antibodies.
Career Highlights
Pei-Jiun Chen has worked with notable companies such as Abgenomics Cooperatief U.A. and Abgenomics Coöperatief U.A. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Some of his notable coworkers include Rong-Hwa Lin and Chung Nan Chang, who have collaborated with him on various projects.
Conclusion
Pei-Jiun Chen's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.